A consultation process has been launched by Heads of Medicines Agencies on their Strategy Paper on the European Medicines Regulatory Network (EMRN).
The Heads of Medicines Agency (HMA) is the working forum of heads of human and veterinary regulatory agencies for medicinal products in the EU member states and the EEA-EFTA states (Iceland, Liechtenstein and Norway).
The HMA Strategy Paper is a contribution to the debate about the future of the Network. The Strategy Paper sets out a vision for development of the network of agencies over the next 3-5 years. It proposes ways of enhancing the protection of public health and animal welfare in the EEA, in response to the evolving regulatory environment.
The Strategy Paper was drafted by the UK Presidency on behalf of the HMA. The HMA agreed to the formation of an Implementation Group. The group will be responsible for taking forward the work set out in the Strategy Paper, including the consultation process and a stakeholders’ meeting.
This stakeholders meeting takes place in Vienna on 12th May, 2006. EPHA members are encouraged to attend wearing EPHA’s hat. The meeting is not reimbursable.
What Can You Do?
EPHA is currently preparing a draft response to the Strategy Paper. We encourage our members to review the document and/or attend the stakeholders meeting.
EPHA would appreciate receiving any comments or contributions to the Strategy Paper by 24th of May, in order to make the Implementation Group’s closing date of 31 May 2006.
Please send your contributions to Eimear O’Loughlin: eimear@epha.org
